Market Overview

Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold


Deutsche Bank's Gregory Gilbert initiated coverage on some of the largest Big Pharma stocks Wednesday morning.

  • Pfizer (NYSE: PFE) - Buy rating and $34 price target - Shares up 0.9 percent to $29.48.
  • Eli Lilly (NYSE: LLY) - Buy and $71 target - Stock up 0.25 percent to $62.97.
  • Merck (NYSE: MRK) - Hold and $63 target - Stock up 0.4 percent to $60.41.
  • Bristol-Myers Squibb (NYSE: BMY) - Hold and $52 target - Shares trading down one percent to $50.25 at last check.

(Click the company's name to see the full-length report.)

The entire healthcare sector, according to the iShares DJ US Healthcare ETF (NYSE: IYH), is up about 0.1 percent. The S&P 500 is currently trading down less than a point to 1,999.43.

Latest Ratings for PFE

Oct 2019ReinstatesNeutral
Aug 2019UpgradesSellHold
Aug 2019MaintainsEqual-Weight

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: News Price Target Initiation Analyst Ratings


Related Articles (IYH + BMY)

View Comments and Join the Discussion!

Latest Ratings

PTONBank of AmericaInitiates Coverage On29.0
ITRICanaccord GenuityMaintains87.0
GWPHNeedhamInitiates Coverage On200.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Best Buy: Problems And Potential

Isis Pharmaceuticals Finally Breaks Out